Innovative Medicines Initiative

6 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	NCT ID
Saracatinib Trial TO Prevent FOP	fibrodysplasia ossificans progressiva, muscle tissue disorder, musculoskeletal system disorder, myositis disease, myositis ossificans	Active, not recruiting	Phase 2	2026-09-02	NCT04307953
Genetic Newborn Screening for Rare Diseases Within the Screen4Care Project	Newborn Screening	Recruiting	Not applicable	2026-05-04	NCT06549218
A Study of the Early Effects, Safety, and Acceptability of Oral Alpibectir in Combination With Ethionamide	Actinomycetales infectious disease, Bacterial Infections and Mycoses, Infections, bacterial infectious disease, gram-positive bacterial infections, lung disorder, mycobacterial infectious disease, pulmonary tuberculosis, respiratory system disorder, respiratory tract infectious disorder, tuberculosis	Recruiting	Phase 2	2025-03-07	NCT06748937
UmbrelLACT Study: Clinical Lactation Study on the Exposure to Medicines Via Human Milk	Breast Feeding; Human Milk	Recruiting	Not stated	2025-02-27	NCT06042803
Development of Novel Clinical Endpoints in Intermediate AMD	eye disorder, macular degeneration, retinal degeneration, retinal disorder	Active, not recruiting	Not stated	2025-01-16	NCT03349801
Understanding RSV: Severe Disease and the Long Term Consequences	Respiratory Syncytial Virus (RSV)	Active, not recruiting	Not stated	2022-11-22	NCT03756766

Clinical trials